Health News

Source:
Date range from to
Keyword:

Moderate weight gain in early adulthood linked to type 2 diabetes in later life

Diabetes UK - 19/07/2017
Moderate weight gain in early adulthood could be linked to health conditions such as type 2 diabetes in later life, a study suggests. The weight of more than 90,000 women and 25,000 men, all of whom were health professionals, were studied as part of the research carried out by the Harvard T H Chan School of Public Health in Boston, Massachusetts. Researchers found that an increase of just 2.5 kg (5.5 pounds) and 10 kg (22.0 pounds) between the ages of 18 and 21 raised the chances in later life of developing type 2 diabetes, high blood pressure, cardiovascular disease, obesity-related cancers,

Life expectancy stalls as lifestyle and degenerative diseases soar, says expert

Diabetes UK - 19/07/2017
A leading academic from University College London (UCL) has warned that the continuous increased life expectancy that has existed up to this point is levelling off. Sir Michael Marmot, a Professor of Epidemiology and Public Health at UCL, attributes this slowdown to how we care for people with lifestyle diseases, like type 2 diabetes, and the elderly. According to Sir Michael, chronic and degenerative diseases of civilisation are top challenges for health systems globally and the way we go about treating them may be all wrong.

Varying HbA1c linked to depression in older people with type 2 diabetes

Diabetes UK - 19/07/2017
Fluctuating long-term HbA1c levels could be linked with symptoms of depression in older people with type 2 diabetes, according to a recent study. An Israeli research team looked at data spanning nine years from 837 people who all had type 2 diabetes and were aged on average about 73. Taking into account the participants' HbA1c levels, they found that for each one per cent of variability, there was a 29 per cent rise in the symptoms of depression.

Early-onset menopause could increase likelihood of developing type 2 diabetes

Diabetes UK - 19/07/2017
Women who experience premature onset of menopause could be more likely to develop type 2 diabetes, a new study reports. Starting the menopause before the age of 40 increased the risk of women developing type 2 diabetes by four-fold, compared to those who experienced late menopause after the age of 55. Scientists from Erasmus University Medical Center in Rotterdam, the Netherlands, confirmed that this independent association existed regardless of other factors such as obesity and genetic predisposition. Co-author Eralda Asllanaj told MedPage Today: "The age at the final menstrual period is cruc

Mindfulness could help lower blood sugar levels in overweight women

Diabetes UK - 18/07/2017
Reducing stress through mindfulness could help lower blood sugar levels and the risk of developing type 2 diabetes, researchers say. A US team from Penn State College of Medicine in Hershey, Pennsylvania, has been looking at the effect of mindfulness-based stress reduction (MBSR) programmes on health markers. The eight-week course combines meditation, body awareness and other anxiety-reducing techniques, and was developed to help people with serious illnesses manage their stress and pain. Lead author Dr Nazia Raja-Khan said: "Our study suggests that MBSR could be a useful tool for preventing o

New gene therapy improves insulin sensitivity and diabetes markers in mice

Diabetes UK - 18/07/2017
New research presented at the last American Heart Association's Scientific Sessions suggests that a therapy called Urocortin 2 gene transfer raises insulin sensitivity in mice. Urocortin 2 (Ucn2), from the corticotropin releasing factor (CRF) family of peptides, binds to and activates a receptor called CRF in insulin resistant cells. The experimental therapy was designed by UCSD Professor of Medicine, Kirk Hammond, who is also co-founder of the biotechnology company delivering it, Renova Therapeutics. Those kind of gene and peptide-based treatments are being tested since 2009 or so for use in

Two major companies team up to develop breakthrough diabetes treatments

Diabetes UK - 18/07/2017
Two major diabetes companies have joined forces to start developing new solutions for people with the condition. Abbott Diabetes Care, which makes blood glucose meters, is joining forces with Bigfoot Biomedical, which specialises in providing insulin delivery solutions. The next generation of Abbott's FreeStyle Libre glucose sensing technology will be given to Bigfoot so it can use the technology to create a pioneering approach to diabetes care and help eliminate much of the daily burden of diabetes management. At the moment Bigfoot is currently developing both injection and infusion pump-base

Manufacturers announce bovine insulin to be discontinued

Diabetes UK - 18/07/2017
The company which makes beef (bovine) insulin has announced the product will be discontinued. Wockhardt UK says the decision is due to worldwide unavailability of the raw materials to make beef insulin, and it has been left with "no chance but to discontinue the Hypurin Bovine insulin range".

Long-term healthy diet linked with lower risks of death

Diabetes UK - 17/07/2017
A new study has found that improving the diet is a marathon, not a sprint, for which consistency is the key. The research suggests that maintaining the healthiest diet as possible for at least 12 years can lead to improvements in risk factors for heart disease, a common complication of diabetes, as well as risks for death. According to researchers from Harvard T.H.

Poor quality sleep could increase risk of Alzheimer's disease

Diabetes UK - 17/07/2017
Just one night of interrupted sleep could increase the risk of Alzheimer's disease, according to a new study. That is the conclusion from an international study involving three universities which has explored the link between Alzheimer's and sleep.

Artificial sweeteners associated with type 2 diabetes and obesity

Diabetes UK - 17/07/2017
Artificial sweeteners could be linked with an increased risk of type 2 diabetes, obesity and heart disease, according to a new review. The evidence has been published in the Canadian Medical Association Journal, which revealed that sweeteners, while designed to aid weight loss, could actually have negative effects on metabolism, appetite and gut bacteria. However, the authors from the University of Manitoba stressed that there aren't enough long-term studies on this data and, consequently, more research is needed to prove whether this association is valid. To better understand how artificial o

Benefits of prescribing social activities for people with long-term conditions

Diabetes UK - 17/07/2017
Prescribing social activities could have the potential to improve the health and wellbeing of people with long-term conditions, researchers say. The concept of 'social prescribing' is where healthcare professionals refer their patients to non-medical, community activities. In this research, activities such as gardening, dancing or volunteering as part of a club were shown to be "successful for patients who engaged with the service". The study, based on the Ways to Wellness programme in Newcastle and conducted by Newcastle University, helped people lose weight and became less anxious and isolat

Increased prevalence of two rare neuropathy types in the US

Diabetes UK - 14/07/2017
A US study finds that two rare types of diabetic neuropathy are now more common in the US, and have urged for people to be aware of the symptoms. Autonomic and small fiber neuropathy develops when the blood vessels which supply the nerves get damaged. The blood vessels then die because of a lack of oxygen and nutrients. In people with diabetes this can be caused by high blood sugar levels, and researchers are now urging people to see their doctor if they experience early symptoms. Dr Divpreet Kaur, a neurologist at Penn State Health Milton S.

Review highlights insulin resistance, not cholesterol, in predicting type 2 diabetes

Diabetes UK - 14/07/2017
A new review has challenged the importance of cholesterol in predicting type 2 diabetes and cardiovascular disease, arguing that insulin resistance is the most important predictor. The review, which appears in The Pharmaceutical Journal, also questions the value of the cholesterol-lowering drug statins, suggesting the benefits have been "grossly exaggerated". The researchers - Drs Maryanne Demasi, Robert H Lustig and Aseem Malhotra - highlight a number of studies where the directive to lower cholesterol using statins has failed to improve health outcomes.

Everyday plastic chemicals linked to type 2 diabetes risk

Diabetes UK - 14/07/2017
Chemicals found in plastic used for food packaging, toys and some medical devices are linked to type 2 diabetes and other chronic conditions in men, research suggests. An Australian study has found that phthalates could also increase the risk of males suffering from cardiovascular disease and high blood pressure. Scientists from the University of Adelaide and the South Australian Health and Medical Research Institute (SAHMRI) tested 1,500 men and found evidence of phthalates in the urine of 99.6 per cent of the participants who were aged 35 or over, although they do not know why. "We found tha

Machine learning techniques analyse effects of weight loss intervention

Diabetes UK - 14/07/2017
Machine learning techniques have revealed that while a healthy weight loss intervention is beneficial for most people, it can lead to worse outcomes in others. The findings indicate that some patients will benefit from certain lifestyle interventions more than others, highlighting the importance of precision medicine in health care. Scientists at the Arnhold Institute for Global Health of the Icahn School of Medicine used new, advanced machine learning techniques to review data of more than 5,000 overweight and obese people with diabetes. The objective was to determine over a 13-year follow-up

Attending annual checks for diabetes can help people live longer

Diabetes UK - 13/07/2017
Yearly checks can increase life expectancy for people with diabetes compared to those who do not receive them, a new report shows. The National Diabetes Audit 2015-16 found that attending the NICE-recommended annual check-ups during the preceding seven-year period helped people with diabetes live longer. The figures show that mortality rate, the rate at which people die, was halved amongst people attending the checks compared to those who didn't.

One in four UK children developing DKA before type 1 diabetes diagnosis

Diabetes UK - 13/07/2017
Children under the age of five have the highest risk of death due to type 1 diabetes being diagnosed too late, new figures show. A report called the 2017 National Paediatric Diabetes Audit found that one in four UK children are diagnosed with type 1 diabetes so late that they develop diabetes ketoacidosis (DKA), a life-threatening complication. The audit, which collected data between 2012 and 2015, also identified increased type 1 diabetes prevalence in the UK as well as subsequent type 1 diabetes hospital admissions.

Children born to women with gestational diabetes could be at risk of attention problems

Diabetes UK - 13/07/2017
Researchers have found an association between babies born to mothers with gestational diabetes and attention problems during infancy. The attentional deficiencies were evident as early as 6-18 months, and scientists from the National University of Singapore believe pre-pregnancy interventions should be considered for women at risk of gestational diabetes. "Our results suggest that the effect of well-controlled GDM on child neurodevelopment is subtle," said lead author Anne Rifkin-Graboi.

Agenda released for third annual Diabetes Professional Care Conference

Diabetes UK - 13/07/2017
The impact of hospital admissions on diabetes control will one of the topics be discussed at the third annual Diabetes Professional Care (DPC) conference. The DPC conference will provide an arena for senior diabetes educators to provide information tailored to the realistic challenges faced by healthcare professionals involved in the treatment, management and prevention of diabetes. Topics which will be covered at the highly anticipated event being held at Olympia, London on 15-16 November, include: Obesity in practice and diabetes prevention Diabetes technologies and research Type 1 diabetes